Beam Therapeutics Inc. (BEAM)

26.73
NASDAQ : Health Technology
Prev Close 30.57
Day Low/High 26.24 / 30.70
52 Wk Low/High 13.00 / 31.80
Avg Volume 264.50K
Exchange NASDAQ
Shares Outstanding 51.49M
Market Cap 1.47B
EPS -1.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

10 Themes Taking Shape for 2014

10 Themes Taking Shape for 2014

If you don't place your bets now, you could fall behind for the rest of the year.

Music to My Ears

Music to My Ears

Here's why I like a lower opening.

Suntory Buys Beam for $16 Billion, Gets Maker's Mark and Jim Beam

Suntory Buys Beam for $16 Billion, Gets Maker's Mark and Jim Beam

Japan's Suntory Holdings said it will buy liquor company Beam for $16 billion, including debt -- receiving iconic American brands like Jim Beam and Maker's Mark.

The Day Ahead: Suntory Guzzles Beam

The Day Ahead: Suntory Guzzles Beam

Company news drives the premarket as futures sag ahead of earnings.

Beam downgraded at Argus

Cramer: Ackman's Dreadful Picks

Cramer: Ackman's Dreadful Picks

I can't think of a worse portfolio to have right now than what Ackman's Gotham has been able to cobble together.

Three of Cups

Three of Cups

Check out these charts with cup-and-handle patterns.

Which Bottle to Crack Open?

Which Bottle to Crack Open?

Out of these two whisky makers, we find Jim Beam more intriguing.

Beam upgraded at Stifel

Beam upgraded at Citi

The Mad Men Portfolio

The Mad Men Portfolio

Want to live in Mad Men style? The stocks in the TheStreet's Mad Men portfolio will make that happen.

Emerging Market Party Not Over for Pernod Ricard

Emerging Market Party Not Over for Pernod Ricard

Gilles Bogaert, CFO of Pernod Ricard, offers his outlook for the rest of 2013 and discusses the company's emerging markets strategy.

FDA Won't Approve Novo Nordisk Insulin: Hot Trends

FDA Won't Approve Novo Nordisk Insulin: Hot Trends

U.S. regulators say they will not approve Novo Nordisk's new long-acting insulin Tresiba until more testing of it is conducted.

Sin Stocks Are In

Sin Stocks Are In

Kevin Dreyer, Associate Portfolio Manager of The Gabelli Asset Fund, discusses his top sin stock picks.

Beam upgraded at Morgan Stanley

Drink To These Stocks

Drink To These Stocks

TheStreet hits the street or rather the bar in this case as Brian Sozzi and Debra Borchardt take a look at alcohol stocks.

Beam upgraded at Argus

Two Defensive Plays

Two Defensive Plays

CVS Caremark and Beam Inc. offer investors a greater probability of advance if market woes continue.

TAP Into a Beverage Play

TAP Into a Beverage Play

Brian Sozzi of Real Money Pro gives you stocks to watch in the spirits space as we approach Cinco de Mayo.

TAP Into a Beverage Play

TAP Into a Beverage Play

Brian Sozzi of Real Money Pro gives you stocks to watch in the spirits space as we approach Cinco de Mayo.

2012's Hottest investment: Scotch Whisky

2012's Hottest investment: Scotch Whisky

Whiskey industry expert David Clelland explains why the market is so hot and talks about his new private club, 1494.

Beam downgraded at Goldman

'Super Bowl Stock' Coca-Cola Reports in Coming Week

'Super Bowl Stock' Coca-Cola Reports in Coming Week

Next week will be another busy week for corporate earnings reports, including those from big blue-chip stocks and web-based companies.

The Day Ahead: Positioning for 'Jobs Friday'

The Day Ahead: Positioning for 'Jobs Friday'

Stocks were poised for a moderately higher ahead of this highly anticipated monthly event.

Getting In the Holiday Spirits

Getting In the Holiday Spirits

A few beverage stocks are dip-buying candidates.

Beam rated new Neutral at JP Morgan